Mercedes Meyer, Ph.D., represents leading life science and technology companies maintaining an extensive biotechnology and pharmaceutical patent management, prosecution, opinion and due diligence practice. With a doctorate in virology and degree in chemistry, Mercedes has a deep understanding of complex biotechnology and scientific research, which is key for advising life science clients on commercializing and protecting product innovations as well as performing diligence for investing in new technologies, particularly in corporate joint development projects. Mercedes advises on developing patent strategies, managing the intellectual property rights, and making associated investments and acquisitions. Mercedes also handles patent reexaminations and inter partes matters.
-
Bryn Mawr College
1988, B.A., Chemistry
-
University of Texas Graduate School of Biomedical Sciences Houston and The M. D. Anderson Cancer Center
1994, Ph.D.
-
University of Houston Law Center
J.D.
Bar Admissions
- District of Columbia
- Texas
Court Admissions
- District of Columbia Court of Appeals
- Superior Court of the District of Columbia
- U.S. Patent and Trademark Office
- Chambers USA – District of Columbia, Intellectual Property: Patent Prosecution, 2021-22
- Managing Intellectual Property – “IP Star”
- Intellectual Asset Management (IAM) – Global Leader, 2022
- Intellectual Asset Management (IAM) 300 Leading IP Strategists
- Intellectual Asset Management (IAM) Patent 1000: The World’s Leading Patent Practitioners
- Legal500 – 2020
- Board Member, Intellectual Property Owners Education Foundation
- Intellectual Property Owners Association
- Association of University Technology Managers Women’s Inventor Committee
- American Intellectual Property Law Association
- Federal Circuit Bar Association
- AIPLA Fellow
